Development of Resistance-Associated Mutations After Sotrovimab Administration in High-risk Individuals Infected With the SARS-CoV-2 Omicron Variant.

ABSTRACT:

SUBMITTER: Birnie E 

PROVIDER: S-EPMC9344387 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature